Midas Letter

VIDEO: FluroTech (CVE:TEST) Launching Cannabis Testing Devices


Listen Later

FluroTech (CVE:TEST) COO Rex H. Kary explains the company’s target markets and main products ahead of its October product launch date. FluroTech’s primary target market is growers; its products reduce growers’ average testing wait time from 10 days to 15 minutes. FluroTech’s device allows growers to test for THC/CBD potency and for contaminants such as heavy metal and pesticides. FluroTech is using this existing technology to develop a roadside test for law enforcement agencies, which Kary estimates is a $150 million market in Canada. FluroTech’s biomarker allows producers to put unique signatures on plants at the cellular level, enabling producers to track their plants through all levels of production and acting as an anti-counterfeiting measure to aide law enforcement agencies.

https://youtu.be/q-2vIkSg1yYVideo can’t be loaded: FluroTech (CVE:TEST) Launching Cannabis Testing Devices (https://youtu.be/q-2vIkSg1yY)
Transcript:

James West:   Hey, welcome back to Midas Letter Live. My guest this segment is Rex Kary; he’s the Chief Operating Officer of FluroTech, which does cannabis testing, and they are publicly traded on the TSX Venture under the symbol TEST. Rex, welcome.

Rex Kary: Thank you. Thank you for having me this morning.

James West:   You bet. Why don’t we start with an overview exactly how your business runs, and what it is you do.

Rex Kary: FluroTech is a startup. What we do is, we test cannabis with a device; that technology came from the University of Calgary. It developed into a device that will test plants; we can test for THC/

...more
View all episodesView all episodes
Download on the App Store

Midas LetterBy James West and Ed Milewski